Drew Moghanaki

Drew Moghanaki, MD, MPH, is a Professor in the Department of Radiation Oncology at UCLA Health. He serves as Chief of Thoracic Oncology and co-directs the VA Greater Los Angeles Lung Precision Oncology Program. His clinical expertise includes high-precision radiation therapy for lung cancers and thymoma, utilizing techniques like SBRT/SABR, IMRT, and MRgRT. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research and leads national initiatives including the VALOR phase III clinical trial.

• Education: MD (Vanderbilt), MPH (UCLA), BS (Cal Poly)
• Training: Residency in Radiation Oncology (University of Pennsylvania), Internship in General Surgery (Vanderbilt)

Dr. Moghanaki focuses on lung cancer early detection, precision oncology, and radiation therapy optimization. His research includes liquid biomarker validation for early detection and comparative effectiveness of radiation vs. surgery. He has secured over $60 million in lung cancer research funding.

Recent publications highlight his work on radiation treatment quality assessment (2020), lung cancer screening implementation protocols (2021), and VA healthcare system improvements. Awards include Howard Hughes Medical Institute Fellowship (1999).

• Labs/Teams: VA Cooperative Studies Program, National Lung Cancer Roundtable (ACS), LUNGevity Foundation
• Advocacy: VA-PALS and CAL-PALS lung screening access programs